Lin Tu
Impact in
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Gastrointestinal Tumor Research and Treatment 20
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 2
- Co-authors
- Wenyi Zhao (21 shared papers)Zhi-gang Zhang (12 shared papers)Chun Zhuang (17 shared papers)Zizhen Zhang (9 shared papers)Hui Cao (13 shared papers)Hui Cao (7 shared papers)Hui Cao (6 shared papers)Ming Wang (8 shared papers)
In The Last Decade
Lin Tu
34 papers receiving 520 citations
Peers
Comparison fields: 5 of 53
- Gastroenterology 159
- Cancer Research 93
- Oncology 75
- Molecular Biology 128
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Lin Tu
This map shows the geographic impact of Lin Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Tu more than expected).
Fields of papers citing papers by Lin Tu
This network shows the impact of papers produced by Lin Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Tu. The network helps show where Lin Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 61 | |
| 2 | Prognostic value of Ki67 index in gastrointestinal stromal tumors. | 2014 | 60 |
| 3 | 2021 | 35 | |
| 4 | 2017 | 29 | |
| 5 | 2016 | 26 | |
| 6 | 2016 | 25 | |
| 7 | 2014 | 24 | |
| 8 | TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion. | 2015 | 22 |
| 9 | Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer. | 2017 | 22 |
| 10 | 2013 | 21 | |
| 11 | 2016 | 21 | |
| 12 | Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling. | 2014 | 19 |
| 13 | Somatostatin receptors in gastrointestinal stromal tumors: new prognostic biomarker and potential therapeutic strategy. | 2014 | 19 |
| 14 | 2016 | 17 | |
| 15 | 2022 | 14 | |
| 16 | 2024 | 14 | |
| 17 | 2016 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 2019 | 11 | |
| 20 | 2018 | 10 |
About Lin Tu
Lin Tu is a scholar working on Gastroenterology, Cancer Research, Pulmonary and Respiratory Medicine, Biomaterials and Pharmaceutical Science, having authored 34 papers that have together received 534 indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (5 papers), RNA Interference and Gene Delivery (2 papers), Cancer-related molecular mechanisms research (2 papers), Nanoparticle-Based Drug Delivery (2 papers), MicroRNA in disease regulation (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper) and Advanced Drug Delivery Systems (1 paper). The work is most often cited by research in Gastroenterology (159 citations), Cancer Research (93 citations), Oncology (75 citations), Molecular Biology (128 citations) and Pulmonary and Respiratory Medicine (54 citations). Lin Tu has collaborated with scholars based in China, Germany and Taiwan. Frequent co-authors include Wenyi Zhao, Zhi-gang Zhang, Chun Zhuang, Zizhen Zhang, Hui Cao, Hui Cao, Hui Cao, Ming Wang, Jia Xu and Chaojie Wang. Their work appears in journals such as Cancer Medicine, Scientific Reports, Medical Oncology, Nature Communications and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.